OpenAI Consider Launching AI-Based Consumer Medical Devices

JAKARTA - OpenAI, the company behind ChatGPT, is reportedly considering developing consumer health products, including agenerative artificial intelligence (AI)-based personal health assistant.

The move marks OpenAI's efforts to expand its business beyond its core AI technology offering, according to a Business Insider report on Monday, November 10, citing close company sources.

Meanwhile, OpenAI declined to comment on the report.

OpenAI's push into the health sector has followed a number of strategic signings in recent months. In June 2025, the company appointed Nate Gross, co-founder of Doximity's network of doctors, as head of health strategies. Then in August, Ashley Alexander, a former Instagram executive, joined as vice president of health products.

This move demonstrates OpenAI's seriousness in entering a billion-dollar digital health market, where AI begins to play an important role in helping patients and medical personnel through data analysis, virtual consultations, and personal health monitoring.

Earlier, Reuters also reported that Microsoft and OpenAI reached a new deal assessing the AI company's value of around $500 billion, marking one of the highest valuations in the global tech industry.